Lactobacillus reuteri UALre-16 and Improved Bowel Movement Frequency

• Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study.

  • 2010-10
  • RCT · n = 44
  • The Journal of Pediatrics 157(4)
  • • P. Coccorullo
    • C. Strisciuglio
    • M. Martinelli
    • E. Miele
    • L. Greco
    • A. Staiano

  • PubMed: 20542295
  • DOI: 10.1016/j.jpeds.2010.04.066

  5 Insights on

  • Improved Bowel Movement Frequency

  • High evidence
  • Highly Cited

  Infants receiving L reuteri (DSM 17938) had a significantly higher frequency of bowel movements than infants receiving a placebo at week 2 (P=.042), week 4 (P=.008), and week 8 (P=.027) of supplementation.

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes